← FDA DRUG APPROVALS

FDA NDA · NDA011525

IC-GREEN

indocyanine green

Sponsor: RENEW PHARMS

APPLICATION
NDA011525
TYPE
NDA
ORIGINAL APPROVAL
1959-02-09
LATEST ACTION
2026-04-22
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription, Discontinued

Products

IC-GREENPrescription
INDOCYANINE GREEN 10MG/VIAL · INJECTABLE · INJECTION
IC-GREEN · ReferencePrescription
INDOCYANINE GREEN 25MG/VIAL · INJECTABLE · INJECTION
IC-GREENDiscontinued
INDOCYANINE GREEN 40MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION
IC-GREENDiscontinued
INDOCYANINE GREEN 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE · INJECTION

Approval history

2026-04-22Labeling · Supplement 43 · standardLetterAP
2026-01-30Manufacturing (CMC) · Supplement 42LabelAP
2024-12-05Efficacy · Supplement 39 · standardLetterAP
2022-08-08Manufacturing (CMC) · Supplement 31LetterTA
2022-03-17Labeling · Supplement 36 · standardLabelAP
2015-10-05Labeling · Supplement 27 · standardLabelAP
2006-09-22Labeling · Supplement 17 · standardLetterAP
1998-03-02Manufacturing (CMC) · Supplement 15 · priorityAP
1997-10-21Manufacturing (CMC) · Supplement 14 · priorityAP
1995-03-30Manufacturing (CMC) · Supplement 13 · priorityAP
1995-03-30Manufacturing (CMC) · Supplement 12 · priorityAP
1991-06-05Labeling · Supplement 11AP
1989-08-02Manufacturing (CMC) · Supplement 9 · priorityAP
1959-02-09Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →